Adaptive Trial Models in Research

Adaptive trial designs are becoming more widely adopted in clinical research due to their ability to adjust to interim results, improving trial efficiency and reducing costs. Recent advancements in adaptive trial models, particularly in oncology and rare diseases, have enabled researchers to modify trial parameters, such as dose levels, patient populations, and endpoints, based on early data. These models allow for quicker decision-making and can accelerate the development of promising therapies. Research has also highlighted the need for robust statistical frameworks to ensure the validity of these trials, enabling flexibility without compromising scientific rigor.

    Related Conference of Adaptive Trial Models in Research

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Adaptive Trial Models in Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in